NCT06914102 Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data Status COMPLETED Phase N/A
NCT06884293 A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06814938 A Study of a Novel Precision Medicine Approach For Obesity Status RECRUITING Phase PHASE4
NCT06803888 Bariatric Surgery vs. Semaglutide vs. Tirzepatide Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06801015 Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06780449 A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06779929 Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Status COMPLETED Phase N/A
NCT06778967 A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06764056 Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Status NOT_YET_RECRUITING Phase NA
NCT06762314 Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes Status RECRUITING Phase PHASE2
NCT06745284 A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06717698 A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease Status RECRUITING Phase PHASE2
NCT06699329 A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023) Status COMPLETED Phase PHASE1
NCT06691243 Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV Status RECRUITING Phase PHASE2
NCT06633783 A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy® Status NOT_YET_RECRUITING Phase PHASE3
NCT06608433 Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function Status COMPLETED Phase NA
NCT06579105 Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE2